Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors plan better treatment for patients receiving isotretinoin. PURPOSE: This clinical trial is studying the side effects and best dose of isotretinoin in treating young patients with high-risk neuroblastoma.

Timeline

Start

2009-02

Primary completion

—

Completion

—

Drugs

Indications